As we've all been told, artificial intelligence (AI) is going to disrupt everything in healthcare, from scheduling a doctor's appointment to developing new medicines. But there's a lot more to AI than large language models (LLMs) like ChatGPT.

In fact, there's a good chance that AI's impact on biotech will go far beyond what consumer-facing AI applications might imply. Investors will accrue many of the benefits. Here's my predictions for how this trend will play out, and why it's bullish.

Image source: Getty Images.

Continue reading

Source Fool.com